Why the study?
Does the AT1R/A1166C polymorphism increase the risk of angiographically-defined coronary artery disease in an Iranian population?
Population
548 subjects in an Iranian population, comprising 413 patients with suspected CAD undergoing coronary…
Comparison
Presence of the AT1R/A1166C polymorphism vs Absence of the polymorphism and healthy control…
Design
Case-control
Authors
Loading...
Does not support AT1R/A1166C as CAD risk marker in Iranians; challenges prior associations and leaves population validation open.
Does the AT1R/A1166C polymorphism increase the risk of angiographically-defined coronary artery disease in an Iranian population?
Assali et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: